Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Foghorn Therapeutics Inc. | 230 000 | déclaré | 30 janv. 2026 | tx 20+608 859−117 718 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 30 janv. 2026 | GRANT_AWARD | Foghorn Therapeutics Inc. | 230 000 | 5.71 USD | deriv |
| 22 janv. 2025 | GRANT_AWARD | Foghorn Therapeutics Inc. | 115 000 | 4.37 USD | deriv |
| 23 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 857 | 3.72 USD | |
| 20 sept. 2024 | SALE | Foghorn Therapeutics Inc. | 35 756 | 10.04 USD | |
| 20 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 35 756 | 3.72 USD | |
| 23 sept. 2024 | SALE | Foghorn Therapeutics Inc. | 857 | 10.17 USD | |
| 23 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 857 | 0.00 USD | deriv |
| 20 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 35 756 | 0.00 USD | deriv |
| 18 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 11 574 | 3.72 USD | |
| 18 sept. 2024 | SALE | Foghorn Therapeutics Inc. | 11 574 | 10.05 USD | |
| 18 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 11 574 | 0.00 USD | deriv |
| 16 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 400 | 3.72 USD | |
| 17 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 10 272 | 3.72 USD | |
| 16 sept. 2024 | SALE | Foghorn Therapeutics Inc. | 400 | 10.00 USD | |
| 17 sept. 2024 | SALE | Foghorn Therapeutics Inc. | 10 272 | 10.04 USD | |
| 16 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 400 | 0.00 USD | deriv |
| 17 sept. 2024 | EXERCISE | Foghorn Therapeutics Inc. | 10 272 | 0.00 USD | deriv |
| 24 janv. 2024 | GRANT_AWARD | Foghorn Therapeutics Inc. | 90 000 | 3.06 USD | deriv |
| 26 janv. 2023 | GRANT_AWARD | Foghorn Therapeutics Inc. | 65 000 | 0.00 USD | deriv |
| 01 août 2022 | GRANT_AWARD | Foghorn Therapeutics Inc. | 50 000 | 0.00 USD | deriv |